NCT07201051: A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
- State
- Under way
- Phase
- Phase 2
- People
- 363 planned
- Started
- 30 Oct 2025
- Primary completion
- 4 May 2027
- Arms
- GSK3862995B Dose Level 1, GSK3862995B Dose Level 2
- Results
- None posted
- 1 Oct 2025: Trial registered
- 30 Oct 2025: Trial started